ProPhase Labs, Inc.
PRPH· OTC
Released Mar 26, 2019, before the open
10-K filed Mar 26, 2019, 85 days after period end · 0001493152-19-003946
derived · Computed from the longer spans the company filed.
| Metric | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015 |
|---|---|---|---|---|
| Revenue | $4.09M | $4.15M | $767.00K | $8.16M |
| Net Income | -$467.00K | -$217.00K |
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR
| -$572.00K |
| -$1.26M |
| EPS Diluted | — | — | — | -$0.07 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.